A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination

被引:6
|
作者
Bazrafshan, Hanieh [1 ]
Jahromi, Leila Sadat Mohamadi [2 ]
Parvin, Reyhaneh [3 ]
Ashraf, Alireza [4 ]
机构
[1] Shiraz Univ Med Sci, Dept Neurol, Clin Neurol Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Shiraz Med Sch, Faghihi Hosp, Dept Phys Med & Rehabil, Shiraz, Iran
[3] Shiraz Univ Med Sci, Faghihi Hosp, Dept Phys Med & Rehabil, Shiraz, Iran
[4] Shiraz Univ Med Sci, Shiraz Med Sch, Dept Phys Med & Rehabil, Shiraz, Iran
关键词
AstraZeneca vaccine; COVID-19; Guillain-Barre syndrome;
D O I
10.5606/tftrd.2022.9984
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Coronavirus disease 2019 (COVID-19) is a novel virus that primarily involves the respiratory system. Due to the COVID-19 pandemic, an extensive vaccination program is underway worldwide. Herein, we present a 68-year-old woman with paresthesia of both hands associated with gait instability, which started three to four days after receiving the second dose of Oxford/AstraZeneca vaccine against the COVID-19 infection. The acute inflammatory demyelinating polyradiculoneuropathy subtype of the Guillain-Barre syndrome, which is the most common subtype, was diagnosed. Regardless of the beneficial effects of the vaccines, this case report aimed to evaluate their severe complications, such as Guillain-Barre syndrome, to reduce their occurrence in the future.
引用
收藏
页码:295 / 299
页数:5
相关论文
共 50 条
  • [1] Guillain-Barre Syndrome After COVID-19 Vaccination in an Adolescent
    Malamud, Emily
    Otallah, Scott I.
    Caress, James B.
    Lapid, Daniel J.
    PEDIATRIC NEUROLOGY, 2022, 126 : 9 - 10
  • [2] Guillain-Barre syndrome after COVID-19 vaccination
    McKean, Norma
    Chircop, Charmaine
    BMJ CASE REPORTS, 2021, 14 (07)
  • [3] Guillain-Barre syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
    Introna, Alessandro
    Caputo, Francesca
    Santoro, Carlo
    Guerra, Tommaso
    Ucci, Maria
    Mezzapesa, Domenico Maria
    Trojano, Maria
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 208
  • [4] GUILLAIN-BARRe SYNDROME FOLLOWING COVID-19 VACCINATION
    Kim, Jee-Eun
    Min, Young Gi
    Shin, Je-Young
    Kwon, Young Nam
    Bae, Jong-Seok
    Sung, Jung-Joon
    Hong, Yoon-Ho
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S165 - S165
  • [5] Association of Guillain-Barre syndrome following COVID-19 vaccination
    Chowdhury, Selia
    Chowdhury, Samia
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [6] Could Guillain-Barre syndrome be triggered by COVID-19 vaccination?
    Aldeeb, Maya
    Okar, Lina
    Mahmud, Safa S.
    Adeli, Gholam A.
    CLINICAL CASE REPORTS, 2022, 10 (01):
  • [7] Prognosis of Guillain-Barre Syndrome Linked to COVID-19 Vaccination
    Chua, Shaun Kai Kiat
    Soh, Qian Ying
    Saffari, Seyed Ehsan
    Tan, Eng-King
    BRAIN SCIENCES, 2022, 12 (06)
  • [8] Guillain-Barre syndrome after COVID-19 vaccination: A systematic review and analysis of case reports
    Abuawwad, Mohammad T.
    Taha, Mohammad J. J.
    Taha, Ahmad J.
    Kozaa, Yasmeena Abdelall
    Falah, Obaida
    Abuawwad, Ibrahim T.
    Hammad, Elsayed Mohamed
    Mahmoud, Ayman A.
    Aladawi, Mohammad
    Abu Serhan, Hashem
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 238
  • [9] A Case of Guillain-Barre Syndrome Associated With COVID-19
    Rajdev, Kartikeya
    Victor, Navin
    Buckholtz, Elaine S.
    Hariharan, Praveen
    Saeed, Muhammad Ahsan
    Hershberger, Daniel M.
    Bista, Sabin
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2020, 8
  • [10] Guillain-Barre Syndrome and COVID-19: A case report
    Bueso, T.
    Montalvan, V
    Lee, J.
    Gomez, J.
    Ball, S.
    Shoustari, A.
    Julayanont, P.
    Jumper, C.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 200